MTNB (Matinas BioPharma Holdings) OCF Yield %: -160.51 (As of Jun. 28, 2026)


MTNB Matinas BioPharma Holdings Inc MTNB
30 GF Score
Price $0.64
! 3 Warning Signs
View Full Analysis

What is Matinas BioPharma Holdings OCF Yield %?

Matinas BioPharma Holdings MTNB +3.15% 30 OCF Yield % is -160.51 as of Jun. 28, 2026. GuruFocus rates MTNB with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 1,417 Biotechnology companies, Matinas BioPharma Holdings ranks worse than 93.93% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Matinas BioPharma Holdings's Trailing 12-Month Cash Flow from Operations is $-6.61 Mil, and Market Cap is $4.12 Mil. Therefore, Matinas BioPharma Holdings's OCF Yield % for today is -160.51%.

The historical rank and industry rank for Matinas BioPharma Holdings's OCF Yield % or its related term are showing as below:

MTNB' s OCF Yield % Range Over the Past 10 Years
Min: -703.25   Med: -11.77   Max: -2.71
Current: -160.51

During the past 13 years, the highest OCF Yield % of Matinas BioPharma Holdings was -2.71%. The lowest was -703.25%. And the median was -11.77%.

MTNB's OCF Yield % is ranked worse than
93.93% of 1417 companies
in the Biotechnology industry
Industry Median: -8.4 vs MTNB: -160.51

Matinas BioPharma Holdings's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Matinas BioPharma Holdings OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Matinas BioPharma Holdings OCF Yield % Related Terms

Matinas BioPharma Holdings OCF Yield % Historical Data

* Premium members only.

The historical data trend for Matinas BioPharma Holdings's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Matinas BioPharma Holdings OCF Yield % Chart

Matinas BioPharma Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.97 -17.63 -32.53 -612.29 -186.76

Matinas BioPharma Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -303.49 -178.56 -52.87 -160.79 -199.94

MTNB vs DRMA, MBIO, ADIL: OCF Yield % Comparison

For the Biotechnology subindustry, Matinas BioPharma Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Matinas BioPharma Holdings OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Matinas BioPharma Holdings's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Matinas BioPharma Holdings's OCF Yield % falls into.


MTNB
30GF Score
Matinas BioPharma Holdings Inc MTNB
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Matinas BioPharma Holdings OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Matinas BioPharma Holdings's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-7.011 / 3.753916
=-186.76%

Matinas BioPharma Holdings's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-1.601 * 4 / 3.203
=-199.94%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -160.51 mean?
Matinas BioPharma Holdings (MTNB) has a OCF Yield % of -160.51 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Matinas BioPharma Holdings and its competitors. According to the industry distribution chart, Matinas BioPharma Holdings ranks #1331 out of 1417 companies in the Biotechnology industry, placing it in the top 93.9%.
Is Matinas BioPharma Holdings' OCF Yield % too high?
Matinas BioPharma Holdings' current OCF Yield % is -160.51. Based on the distribution chart, Matinas BioPharma Holdings ranks #1331 out of 1417 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Matinas BioPharma Holdings has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Matinas BioPharma Holdings' OCF Yield % compare to DRMA and MBIO?
According to the Biotechnology industry distribution chart, Matinas BioPharma Holdings ranks #1331 out of 1417 companies for OCF Yield %. This places Matinas BioPharma Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Matinas BioPharma Holdings and its competitors. Matinas BioPharma Holdings's current OCF Yield % is -160.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Matinas BioPharma Holdings stock overvalued right now?
Matinas BioPharma Holdings (MTNB) has a current OCF Yield % of -160.51. The current OCF Yield % is -160.51. Matinas BioPharma Holdings' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Matinas BioPharma Holdings (MTNB), the current OCF Yield % is -160.51 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Matinas BioPharma Holdings Business Description

Address 1545 Route 206 South, Suite 302, Bedminster, NJ, USA, 07921
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
30GF Score

Get the complete analysis for MTNB

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64
Price